Guardant Health Company Top Insiders

GH Stock  USD 17.59  1.52  9.46%   
Under 75% of Guardant Health's corporate insiders are selling. The analysis of insiders' sentiment of trading Guardant Health stock suggests that many insiders are alarmed at this time. Guardant Health employs about 1.8 K people. The company is managed by 25 executives with a total tenure of roughly 95 years, averaging almost 3.0 years of service per executive, having 70.72 employees per reported executive.
Helmy Eltoukhy  CEO
CoCEO CoFounder
AmirAli Talasaz  President
President COO, Director

Guardant Health's Insider Buying Vs Selling

25

 
Selling
 
Buying

Latest Trades

2024-03-18Kumud KaliaAcquired 2187 @ 17.82View
2024-03-04Meghan V JoyceDisposed 100 @ 19.05View
2023-12-04Meghan V JoyceDisposed 100 @ 26.34View
2023-12-01Kumud KaliaDisposed 5800 @ 26.37View
2023-09-12Kumud KaliaDisposed 2125 @ 32.59View
2023-09-05Meghan V JoyceDisposed 100 @ 35.01View
2023-06-15Meghan V JoyceDisposed 2766 @ 37.55View
2023-06-09Kumud KaliaAcquired 2981 @ 32.71View
Monitoring Guardant Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Guardant Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Guardant Health's future performance. Based on our forecasts, it is anticipated that Guardant will maintain a workforce of under 1770 employees by May 2024.
 
Covid

Guardant Health's latest congressional trading

Congressional trading in companies like Guardant Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Guardant Health by those in governmental positions are based on the same information available to the general public.
2022-02-28Representative Donald S. Beyer, Jr.Disposed Under $15KVerify

Guardant Health Management Team Effectiveness

The company has Return on Asset (ROA) of (0.1764) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1764. This is way below average. Likewise, it shows a return on total equity (ROE) of (4.3813) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.28. The current Return On Capital Employed is estimated to decrease to -0.37. As of now, Guardant Health's Debt To Assets are increasing as compared to previous years. The Guardant Health's current Fixed Asset Turnover is estimated to increase to 2.51, while Total Assets are projected to decrease to under 1.4 B.
The current Common Stock Shares Outstanding is estimated to decrease to about 92.9 M. The Guardant Health's current Net Loss is estimated to increase to about (559.7 M)

Guardant Health Workforce Comparison

Guardant Health is rated below average in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 241,827. Guardant Health maintains roughly 1,768 in number of employees contributing less than 1% to equities under Health Care industry.

Guardant Health Profit Margins

The company has Net Profit Margin (PM) of (0.85) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.73) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.73.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.430.5974
Way Down
Slightly volatile

Guardant Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardant Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardant Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Guardant Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
0.5625
9
16
 15,517 
 21,979 
2024-03-01
0.7333
33
45
 850,106 
 2,330,359 
2023-12-01
1.0294
35
34
 354,506 
 57,934 
2023-09-01
0.7143
25
35
 283,145 
 30,269 
2023-06-01
1.2105
46
38
 353,496 
 193,749 
2023-03-01
1.1579
22
19
 211,181 
 27,279 
2022-12-01
1.6667
20
12
 324,220 
 5,845 
2022-09-01
1.1667
7
6
 172,502 
 13,218 
2022-06-01
0.619
13
21
 104,894 
 290,243 
2022-03-01
0.5
4
8
 18,110 
 34,158 
2021-12-01
3.2857
23
7
 245,325 
 29,604 
2021-09-01
0.9231
12
13
 175,417 
 80,035 
2021-06-01
0.2045
18
88
 86,086 
 858,232 
2021-03-01
0.0529
9
170
 1,149,490 
 3,775,907 
2020-12-01
0.2895
11
38
 72,484 
 7,341,725 
2020-09-01
0.225
18
80
 351,403 
 1,322,166 
2020-06-01
0.3861
39
101
 3,604,883 
 9,881,143 
2020-03-01
0.3684
14
38
 108,877 
 402,992 
2019-12-01
0.2857
32
112
 344,306 
 1,029,913 
2019-09-01
0.2645
41
155
 699,086 
 6,569,444 
2019-06-01
0.2131
26
122
 316,133 
 1,401,323 
2019-03-01
2.0
2
1
 4,067,980 
 3,000 
2018-12-01
0.717
38
53
 62,484,930 
 89,760,664 

Guardant Health Notable Stakeholders

A Guardant Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Guardant Health often face trade-offs trying to please all of them. Guardant Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Guardant Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Helmy EltoukhyCoCEO CoFounderProfile
AmirAli TalasazPresident COO, DirectorProfile
Marcel RocheVice President - FinanceProfile
DEREK BERTOCCICFOProfile
Ian ClarkLead Independent DirectorProfile
Aaref HilalyIndependent DirectorProfile
Dipchand NisharIndependent DirectorProfile
Bahija JallalDirectorProfile
Stanley MeresmanIndependent DirectorProfile
Samir KaulIndependent DirectorProfile
Richard LanmanChief Medical OfficerProfile
Leena DasYoungGeneral Manager,Chief LUNAR OfficerProfile
John SaiaChief SecretaryProfile
Terilyn MonroeChief OfficerProfile
Craig MDChief OfficerProfile
Andy AmentVP OperationsProfile
Kumud KaliaChief OfficerProfile
Michael BellChief OfficerProfile
Michael WileyChief Legal OfficerProfile
Darl MorelandSenior QualityProfile
Jennifer HigginsVice AffairsProfile
Christopher FreemanChief OfficerProfile
Mark JacobsteinChief User Engagement OfficerProfile
Lynn LewisIR Contact OfficerProfile
Darya ChudovaVP TechnologyProfile

About Guardant Health Management Performance

The success or failure of an entity such as Guardant Health often depends on how effective the management is. Guardant Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guardant management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guardant management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.27)(0.28)
Return On Capital Employed(0.36)(0.37)
Return On Assets(0.27)(0.28)
Return On Equity(3.02)(3.17)
The data published in Guardant Health's official financial statements usually reflect Guardant Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Guardant Health. For example, before you start analyzing numbers published by Guardant accountants, it's critical to develop an understanding of what Guardant Health's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Guardant Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Guardant Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Guardant Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Guardant Health. Please utilize our Beneish M Score to check the likelihood of Guardant Health's management manipulating its earnings.

Guardant Health Workforce Analysis

Traditionally, organizations such as Guardant Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Guardant Health within its industry.

Guardant Health Manpower Efficiency

Return on Guardant Health Manpower

Revenue Per Employee319K
Revenue Per Executive22.6M
Net Loss Per Employee271.2K
Net Loss Per Executive19.2M
Working Capital Per Employee645.5K
Working Capital Per Executive45.6M
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.